awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47770899-0993865B-824B-46ED-B991-0A396170C394
Q47770899-0993865B-824B-46ED-B991-0A396170C394
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47770899-0993865B-824B-46ED-B991-0A396170C394
Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission.
P2860
Q47770899-0993865B-824B-46ED-B991-0A396170C394
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47770899-0993865B-824B-46ED-B991-0A396170C394
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc142a0bdcba2153fe3a11730150f1db724506f1
P2860
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.